Clinical Updates

Monitoring Coronavirus Concerns - Carlisle Medical
Carlisle Medical Monitoring Coronavirus Concerns

Carlisle Medical continues to monitor concerns for potential disruptions in the availability of medications and…

Mar 06, 2020
FDA Approves Three Drugs for OTC Use
FDA Approves Three Drugs for OTC Use

Last week, the FDA approved three medications for over-the-counter (OTC) use through a process called…

Mar 02, 2020
Generic Zohydro Is Now Available
Generic Zohydro Is Now Available

The generic formulation of Zohydro, hydrocodone bitartrate ER, has been released by Macoven Pharmaceuticals. Zohydro…

Jan 30, 2020
December 2019 Generic Drug Update
Generic Drug Update

Launch of Generic Travatan Z A generic is now available for the ophthalmic drug Travatan…

Dec 31, 2019
FDA Approves New Migraine Treatments
FDA Approves New Migraine Treatments

Two new medications for the treatment of acute migraine with or without aura in adults…

Dec 30, 2019
FDA Releases Warning Regarding Gabapentin and Pregabalin
FDA Releases Warning Regarding Gabapentin and Pregabalin

The FDA recently released a warning for the medications, gabapentin (Neurontin, Gralise, Horizant) and pregabalin…

Dec 23, 2019
FDA Alert Concerning Ranitidine Products
FDA Alert Concerning Ranitidine Products

By: Heidi Dufrene, Pharmacy Director Earlier this month, the U.S. Food and Drug Administration (FDA)…

Sep 25, 2019
The U.S. DEA Proposes Production Cuts to Five Opioids in 2020
The U.S. DEA Proposes Production Cuts to Five Opioids in 2020

The U.S. DEA (Drug Enforcement Administration) released a Notice of Proposed Rulemaking in the Federal…

Sep 16, 2019
Generic Launch of Rozerem
Generic Launch of Rozerem

The generic equivalent of Rozerem (Ramelteon) is now available. Rozerem is FDA approved for the…

Jul 29, 2019
Launch of Generic Lyrica
Launch of Generic Lyrica

The U.S. Food and Drug Administration (FDA) has approved the launch of generic Lyrica (pregabalin)….

Jul 24, 2019
  • This field is for validation purposes and should be left unchanged.


Filter Articles

Should a claimant need this much pain medication for this long? Are claimants utilizing medications or selling on the black market?

The prevalence of opioid use and abuse among those with chronic pain has developed into one of the most pressing issues today. Download the white paper to learn facts about the opioid crisis and possible solutions to avoid prescriptions that could lead to abuse.

Download Now